Tabula Rasa HealthCare Inc (NASDAQ:TRHC) CEO Calvin H. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction that occurred on Monday, October 8th. The shares were sold at an average price of $74.22, for a total transaction of $593,760.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
NASDAQ TRHC opened at $74.38 on Friday. The firm has a market cap of $1.64 billion, a price-to-earnings ratio of -1,859.50, a P/E/G ratio of 6.13 and a beta of 2.85. Tabula Rasa HealthCare Inc has a fifty-two week low of $24.24 and a fifty-two week high of $91.16. The company has a current ratio of 0.36, a quick ratio of 0.33 and a debt-to-equity ratio of 0.11.
Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Tuesday, August 7th. The company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.08 by $0.12. The firm had revenue of $48.60 million for the quarter, compared to analysts’ expectations of $46.73 million. Tabula Rasa HealthCare had a negative net margin of 16.78% and a positive return on equity of 4.55%. As a group, sell-side analysts predict that Tabula Rasa HealthCare Inc will post 0.53 earnings per share for the current year.
Several hedge funds and other institutional investors have recently bought and sold shares of the business. BlackRock Inc. grew its stake in shares of Tabula Rasa HealthCare by 29.7% during the second quarter. BlackRock Inc. now owns 2,119,507 shares of the company’s stock worth $135,288,000 after buying an additional 484,979 shares during the last quarter. Jennison Associates LLC grew its stake in shares of Tabula Rasa HealthCare by 29.5% during the second quarter. Jennison Associates LLC now owns 757,846 shares of the company’s stock worth $48,373,000 after buying an additional 172,693 shares during the last quarter. NN Investment Partners Holdings N.V. bought a new stake in shares of Tabula Rasa HealthCare during the second quarter worth $29,439,000. Braun Stacey Associates Inc. grew its stake in shares of Tabula Rasa HealthCare by 199.0% during the second quarter. Braun Stacey Associates Inc. now owns 301,089 shares of the company’s stock worth $19,219,000 after buying an additional 200,394 shares during the last quarter. Finally, Northern Trust Corp grew its stake in shares of Tabula Rasa HealthCare by 52.3% during the second quarter. Northern Trust Corp now owns 227,503 shares of the company’s stock worth $14,522,000 after buying an additional 78,112 shares during the last quarter. 75.15% of the stock is currently owned by hedge funds and other institutional investors.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.
Featured Story: Leveraged Buyout (LBO)
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.